AUDAustralian owned & operated
Card Payments Available
AUD
Images are for illustration purpose only
CagriSema 10mg
★★★★★
4 ReviewsThis listing is for 1 × CagriSema 10mg vial only. CagriSema is a pre-blended lyophilised research material combining Cagrilintide (5mg) and Semaglutide (5mg) in a single vial, supplied for dual amylin and GLP-1 receptor interaction studies, combination pathway research, and comparative agonist investigations in experimental models. Specifications include ≥99% purity and storage at -20°C protected from light and moisture. Batch-specific analytical documentation is available via the Current Batch panel.
Research Use Only: This product is strictly for laboratory research and is not intended for human or veterinary consumption, therapeutic use, diagnostic use, or clinical application.
Useful Resources:
Full Manufacturer QC Panel Passed
Each batch undergoes a full manufacturer QC panel prior to release.
Manufacturer QC confirms batch release against internal quality specifications.
Detailed manufacturer QC results are not publicly displayed.
Third-party testing in progress
Additional third-party testing is currently in progress for this batch.
Verified third-party results will be published here once available.
$149.95 AUD
Quantity
1
Product Overview
Understanding CagriSema 10mg
CagriSema 10mg is a pre-blended lyophilised research material combining Cagrilintide (5mg) and Semaglutide (5mg) in a single vial for in-vitro laboratory and analytical use. This dual-component blend enables simultaneous investigation of amylin receptor and GLP-1 receptor pathway interactions, receptor crosstalk mechanisms, and synergistic signalling in laboratory models. Products selected for website presentation meet Solatide Biosciences' ≥99% purity standard based on available third-party documentation.
Research Applications
•Dual GLP-1 and Amylin Receptor Pathway Studies: Investigate simultaneous amylin and GLP-1 receptor activation and downstream pathway modulation in vitro.
•Receptor Crosstalk and Synergistic Signalling: Study CagriSema-mediated receptor pathway interactions and synergistic signalling consequences in experimental models.
•Comparative Single-Agent vs Combination Research: Compare CagriSema combination effects against individual Cagrilintide or Semaglutide in receptor binding assays.
•Metabolic Signalling Pathway Analysis: Examine combined amylin and incretin receptor metabolic signalling in experimental cell models.
This analytical standard is strictly for in-vitro laboratory research use only.
Technical Specifications
Technical Parameter
Laboratory Specification
Purity
≥99% based on available third-party documentation
Composition
5mg Cagrilintide + 5mg Semaglutide
Total Content
10mg per vial
CAS Number (Cagrilintide)
2413927-92-9
CAS Number (Semaglutide)
910463-68-2
Appearance
White Lyophilised Powder
Batch-specific third-party documentation available. Reports may include testing from independent laboratories such as Janoshik, Chromate, and Freedom Diagnostics, depending on the batch. View our COA & Lab Testing page for details.
Reviews
Customer Reviews
5.0
★★★★★
Based on 4 verified reviewsC
Chris B
06/05/2026
Would buy again
Such a good price
C
Chris
18/03/2026
Can't find this stuff anywhere for this price, been a customer of Solatide and they have very fair priicng and great quality so was happy to see they stock this
A
Ash
29/12/2025
Trusted them
I was cautious because I had not paid by transfer before, but they handled it professionally.
A
Amelia
18/12/2025
Happy with price
Happy with the price. That was the main thing for me.
FAQ
For complete information, see our full FAQ pageKey Questions
More Products
View All Product→You may also like:
In Stock4.9$79.95 AUD
In Stock4.8$119.95 AUD
In Stock5$119.95 AUD
In Stock4.9$74.95 AUD
In Stock5$109.95 AUD